These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 39066214)
1. Alipour-Khezri E; Skurnik M; Zarrini G Viruses; 2024 Jun; 16(7):. PubMed ID: 39066214 [TBL] [Abstract][Full Text] [Related]
2. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
3. Activity of Bacteriophages in Removing Biofilms of Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773 [No Abstract] [Full Text] [Related]
7. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Wang Z; De Soir S; Glorieux A; Merabishvili M; Knoop C; De Vos D; Pirnay JP; Van Bambeke F Int J Antimicrob Agents; 2024 Sep; 64(3):107276. PubMed ID: 39009289 [TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential. Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933 [TBL] [Abstract][Full Text] [Related]
9. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
10. Improving the Inhibitory Effect of Phages against Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028 [TBL] [Abstract][Full Text] [Related]
11. Relevance of the bacteriophage adherence to mucus model for Almeida GMdF; Ravantti J; Grdzelishvili N; Kakabadze E; Bakuradze N; Javakhishvili E; Megremis S; Chanishvili N; Papadopoulos N; Sundberg L-R Microbiol Spectr; 2024 Aug; 12(8):e0352023. PubMed ID: 38912817 [No Abstract] [Full Text] [Related]
13. Characterization of a new Whiteley LE; Whiteley M Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients. Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328 [TBL] [Abstract][Full Text] [Related]
15. Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis. Martínez-Gallardo MJ; Villicaña C; Yocupicio-Monroy M; Alcaraz-Estrada SL; León-Félix J Folia Microbiol (Praha); 2023 Feb; 68(1):1-16. PubMed ID: 35931928 [TBL] [Abstract][Full Text] [Related]